140 computer-security-"https:"-"https:"-"https:"-"https:"-"https:"-"UCL" positions at ETH Zurich
Sort by
Refine Your Search
-
natural plant defenses and reduce pathogen entry into leafy vegetables, contributing to sustainable agriculture and improved food safety.
-
to commercial-grade systems, we are seeking a visionary Lead Architect to drive the design and development of the V2.0 system. This role is critical for establishing technical novelty, securing a new IP portfolio
-
. Profile Ph.D. in Nuclear Engineering, Physics, Chemical Engineering, or a related field. Experience with computational chemistry and simulation tools. Prior knowledge of nuclear safety, severe accident
-
100%, Basel, fixed-term The Computational Biology (CoBi) group, led by Prof. Dagmar Iber, develops data-driven, mechanistic models of biological systems using advanced imaging and computational
-
transfer, developing and employing laboratory experiments, computer simulations, and field analyses. Our aim is to gain fundamental insights and to develop sustainable technologies that address societal
-
organised individual to support multiple experimental and computational research groups. The successful candidate will contribute to both a collaborative research network and institute-wide activities
-
work closely with Professor Platt, guide the group’s computational research, contribute to ongoing projects, and pursue independent research directions aligned with the laboratory’s goals. Project
-
-phonon coupling elements. With these, dedicated scattering rates can be computed and then used in quantum transport simulations. Down the line, we aim to pre-train a common GNN backbone model capable
-
dynamical systems, and machine learning, with applications to synthetic biology and biomolecular circuit design. Our research develops mathematical and computational frameworks for understanding and
-
100%, Basel, fixed-term The highly competitive Bio-Engineering Systems for Therapeutics (BEST) postdoc program, part of the Next-gen Bioengineers initiative, is run jointly by ETH Zurich and Roche